• Share your story
  • Sustainability
  • Partnerships
  • News
  • Medical Information
Pacira logo
  • Company
    • About us
    • Leadership
    • Impact
  • Therapies
    • Reimagining pain relief
    • EXPAREL
    • iovera°
    • ZILRETTA
  • Innovation
    • Pipeline
    • PCRX-201
    • Clinical trials
    • pMVL technology
  • Patients
    • Explore insights
    • Understand pain
    • Plan ahead
    • Get involved
  • Careers
    • Life at Pacira
    • Benefits
    • Open positions
  • Investors
    • Overview
    • Events
    • SEC filings
    • Analyst coverage
    • Corporate governance
    • Investor toolkit
    • Investor FAQ
  • Share your story
  • Sustainability
  • Partnerships
  • News
  • Medical Information
  • Search Button
  1. Home
  2. Sitemap

Sitemap

Company

About us
Leadership
Impact

Therapies

Reimagining pain relief
EXPAREL
ioveraº
ZILRETTA

Innovation

Pipeline
PCRX-201
Clinical trials
pMVL technology

Patients

Explore insights
Understand pain
Plan ahead
Get involved

Careers

Life at Pacira
Benefits
Open positions

Investors

Overview
Events
SEC Filings
Analyst coverage
Corporate governance
Investors toolkit
Investor FAQ

Auxillary

Sustainability
Partnerships
Contact us
Legal
Privacy notice
Terms of use
Accessibility statement

  • Pacira LinkedIn
  • X
  • YouTube
  • Instagram
  • Share your story

EXPAREL® (bupivacaine liposome injectable suspension), ioverao, ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), and Pacira are registered trademarks of the respective subsidiaries of Pacira BioSciences, Inc. All other trademarks referenced herein are the property of their respective owners.


  • Contact
  • Legal
  • Sitemap
  • Privacy Notice
  • Terms of Use
  • Accessibility Statement
  • Medical Information

© 2025 Pacira Pharmaceuticals, Inc., a wholly owned subsidiary of Pacira BioSciences, Inc. PP-MP-US-0289

The pacira website is intended for us residents only

Are you a US resident?

No
You are now leaving Pacira.com